Granite Bio
Basel
About Granite Bio
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $100.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2025)
- Website: granitebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/granite-bio-9051 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.